An article on the benefits of tailoring an individual’s work schedule around their circadian rhythm and optimum times of productivity was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the last week: 1. How ‘Chronoworking’ is helping boost employee productivity, recruitment 2. FSRA releases final […]
Mental-health claims by Canadians have increased by 132 per cent since the onset of the coronavirus pandemic, according to a new report by GreenShield. The report, which compiled data from the insurer’s claims database between 2020 to 2023, found women and younger generations account for the majority of mental-health services accessed. Among those accessing mental-health services, stress […]
Roughly a third (34 per cent) of employers in the U.S. are providing coverage for glucagon-like peptide-1 medications for both diabetes care and weight-loss management in 2024, up from 26 per cent in 2023, according to a new survey by the International Foundation of Employee Benefit Plans. However, the survey, which polled more than 270 U.S. employers, found more […]
An article detailing a stark increase in the use of obesity medications among Canadian employer-sponsored benefits plan members was the most-read article on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. Claims for obesity drugs increased 42% in 2023, 92% since 2020: report 2. How […]
As someone who has become increasingly overweight in the last few years, every time I read or write about obesity being referred to as a ‘lifestyle condition’ it makes me physically cringe. Yes, some poor diet choices have contributed to my current physical condition, but it’s much more complex than that. And I know others […]
Obesity has long been misunderstood and stigmatized as a lifestyle condition instead of a complex disease, said Rami Halabi, a medical science liaison with Novo Nordisk, during a webinar hosted by Benefits Canada and sponsored by Novo Nordisk in November. The condition isn’t just a measure of size, but a progressive, relapsing chronic disease characterized […]
While three-quarters (76 per cent) of U.S. employers say they provide coverage of glucagon-like peptide-1 drugs for diabetes management, about a quarter (27 per cent) provide coverage of these drugs for weight loss, according to a new survey by the International Foundation of Employee Benefit Plans. The survey, which polled more than 200 U.S. benefits […]